<SEC-DOCUMENT>0001143313-18-000054.txt : 20180927
<SEC-HEADER>0001143313-18-000054.hdr.sgml : 20180927
<ACCEPTANCE-DATETIME>20180927132505
ACCESSION NUMBER:		0001143313-18-000054
CONFORMED SUBMISSION TYPE:	25-NSE
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20180927
DATE AS OF CHANGE:		20180927
EFFECTIVENESS DATE:		20180927

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOTIME INC
		CENTRAL INDEX KEY:			0000876343
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				943127919
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		25-NSE
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12830
		FILM NUMBER:		181090320

	BUSINESS ADDRESS:	
		STREET 1:		1010 ATLANTIC AVENUE
		STREET 2:		SUITE 102
		CITY:			ALAMEDA
		STATE:			CA
		ZIP:			94501
		BUSINESS PHONE:		5105213390

	MAIL ADDRESS:	
		STREET 1:		1010 ATLANTIC AVENUE
		STREET 2:		SUITE 102
		CITY:			ALAMEDA
		STATE:			CA
		ZIP:			94501

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NYSE AMERICAN LLC
		CENTRAL INDEX KEY:			0001143313
		IRS NUMBER:				522127241

	FILING VALUES:
		FORM TYPE:		25-NSE

	BUSINESS ADDRESS:	
		STREET 1:		11 Wall Street
		CITY:			New York
		STATE:			NY
		ZIP:			10005
		BUSINESS PHONE:		212-656-5414

	MAIL ADDRESS:	
		STREET 1:		11 Wall Street
		CITY:			New York
		STATE:			NY
		ZIP:			10005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NYSE MKT LLC
		DATE OF NAME CHANGE:	20120514

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NYSE Amex
		DATE OF NAME CHANGE:	20090402

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NYSE Alternext US LLC
		DATE OF NAME CHANGE:	20081009
</SEC-HEADER>
<DOCUMENT>
<TYPE>25-NSE
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<notificationOfRemoval>

    <schemaVersion>X0203</schemaVersion>

    <exchange>
        <cik>0001143313</cik>
        <entityName>NYSE AMERICAN LLC</entityName>
    </exchange>

    <issuer>
        <cik>876343</cik>
        <entityName>BIOTIME INC</entityName>
        <fileNumber>001-12830</fileNumber>
        <address>
            <street1>1301 Harbor Bay Parkway</street1>
            <street2></street2>
            <city>Alameda</city>
            <stateOrCountryCode>CA</stateOrCountryCode>
            <stateOrCountry>CALIFORNIA</stateOrCountry>
            <zipCode>94502</zipCode>
        </address>
        <telephoneNumber>(972) 533-2820</telephoneNumber>
    </issuer>

    <descriptionClassSecurity>Common Share Purchase Warrants</descriptionClassSecurity>

    <ruleProvision>17 CFR 240.12d2-2(a)(3)</ruleProvision>

    <signatureData>
        <signatureName>Victoria Paper</signatureName>
        <signatureTitle>Senior Analyst</signatureTitle>
        <signatureDate>2018-09-27</signatureDate>
    </signatureData>
</notificationOfRemoval>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.25
<SEQUENCE>2
<FILENAME>ruleprovisionnotice.htm
<TEXT>
NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES

The NYSE American LLC hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on October 8, 2018, pursuant to the provisions of Rule 12d2-2 (a).

[  X  ] 17 CFR 240.12d2-2(a)(3)  That on September 27, 2018 the instruments representing the securities comprising the entire class of this security came to evidence, by operation of law or otherwise, other securities in substitution therefore and represent no other right except, if such be the fact, the right  to receive an immediate cash payment.

Pursuant to the terms of the Warrant Agreement, each warrant to purchase 1.1 shares of BioTime Inc. at an exercise price of $4.55 per share will expire on October 1, 2018.

The Exchange also notifies the Securities and Exchange Commission that as a result of the above indicated conditions this security was suspended from trading on September 27, 2018.
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
